News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biocontrol Spins Off Epilepsy Treatment Unit; Will Keep its Heart Attack Treatment Business
June 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Medical devices company BioControl Medical Ltd. will spin off its epilepsy treatment business into a new company, Cerebral RX Ltd. BioControl will keep its heart attack treatment business.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
MORE ON THIS TOPIC
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Vertex Terminates 20 in Reorganization Push
March 9, 2026
·
32 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
March 6, 2026
·
1 min read
·
Annalee Armstrong
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
March 5, 2026
·
2 min read
·
Heather McKenzie
